Zoetis Inc. (ZTS): Price and Financial Metrics

Zoetis Inc. (ZTS): $155.06

6.61 (-4.09%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

A

ZTS Price/Volume Stats

Current price $155.06 52-week high $200.33
Prev. close $161.67 52-week low $139.70
Day low $154.54 Volume 4,662,400
Day high $158.11 Avg. volume 3,028,321
50-day MA $158.96 Dividend yield 1.22%
200-day MA $170.89 Market Cap 69.03B

ZTS Stock Price Chart Interactive Chart >


Zoetis Inc. (ZTS) Company Bio


Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets the products in approximately 45 countries, and sells the products in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index. (Source:Wikipedia)


ZTS Latest News Stream


Event/Time News Detail
Loading, please wait...

ZTS Latest Social Stream


Loading social stream, please wait...

View Full ZTS Social Stream

ZTS Price Returns

1-mo -5.25%
3-mo -4.57%
6-mo -5.33%
1-year N/A
3-year N/A
5-year 17.55%
YTD -4.22%
2024 -16.63%
2023 35.91%
2022 -39.51%
2021 48.26%
2020 25.76%

ZTS Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full ZTS Dividend History

Continue Researching ZTS

Here are a few links from around the web to help you further your research on Zoetis Inc's stock as an investment opportunity:

Zoetis Inc (ZTS) Stock Price | Nasdaq
Zoetis Inc (ZTS) Stock Quote, History and News - Yahoo Finance
Zoetis Inc (ZTS) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!